Immunopathogenesis of adrenoleukodystrophy: current understanding.

TitleImmunopathogenesis of adrenoleukodystrophy: current understanding.
Publication TypeJournal Article
Year of Publication2007
AuthorsHudspeth MP, Raymond GV
JournalJournal of neuroimmunology
Volume182
Issue1-2
Pagination5-12
Date Published2007 Jan
Abstract

Adrenoleukodystrophy is a neurometabolic disease with a decreased ability to degrade very long chain fatty acids (VLCFA) and significant phenotypic variation. Unlike most neurometabolic diseases, the success of hematopoietic stem cell transplantation (HSCT) is based on acquiring a new immune system rather than enzyme replacement. VLCFA accumulation appears necessary but not sufficient for pathogenesis. Evidence for the involvement of different components of the immune system in the pathogenesis of the cerebral lesions (cellular, cytokines, humoral, and complement) is reviewed, along with both HSCT and non-HSCT immunologic approaches to treatment and future directions.

DOI10.1371/journal.pone.0064024
Alternate JournalJ. Neuroimmunol.